Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00357922

Ligand	Ligand name	Chain	PDB	Tanimoto
SMA	STIGMATELLIN A	A,C,D,E,N,P,Q,R	3H1I	0.71
SMA	STIGMATELLIN A	A,B,C,D,E,F,G,O,P,Q,R,S,T	1PPJ	0.71
SMA	STIGMATELLIN A	A,C,D,E,L,N,O,P,W	3CXH	0.71
SMA	STIGMATELLIN A	C,D,E,P,Q,R	1ZRT	0.71
SMA	STIGMATELLIN A	C,H,L,M	2JBL	0.71
SMA	STIGMATELLIN A	A,B,C,D,E,F,G,I,N,O,P,Q,R,S,T,U,V,W	2A06	0.71
SMA	STIGMATELLIN A	A,B,C,D,E,F,G,H,I,J,K,L	2QJP	0.71
SMA	STIGMATELLIN A	A,C,D,E	1KB9	0.71
SMA	STIGMATELLIN A	A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R	2QJK	0.71
SMA	STIGMATELLIN A	A,B,C,D,E,F,G,N,O,P,Q,R,S,T	1PP9	0.71
SMA	STIGMATELLIN A	C,D,E	2IBZ	0.71
SMA	STIGMATELLIN A	A,C,D,E,L,N,O,P,W	3CX5	0.71
SMA	STIGMATELLIN A	A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R	2FYN	0.71
SMA	STIGMATELLIN A	A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R	2QJY	0.71
SMA	STIGMATELLIN A	C,D,E	1EZV	0.71
SMA	STIGMATELLIN A	C,D,E,N,O,P,W	1KYO	0.71
SMA	STIGMATELLIN A	A,C,D,E,G,N,P,Q,R,S	3H1J	0.71
SMA	STIGMATELLIN A	C,D,E	1SQX	0.71
U03	4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE	A	3UPJ	0.7
5PP	5-PENTYL-2-PHENOXYPHENOL	A,B,C,D,E,F	2B36	0.71
8PS	5-OCTYL-2-PHENOXYPHENOL	A,B,C,D,E,F	2B37	0.71
VXX	VANILLATE	A,B	1WB6	0.72
IKR	methyl (2E)-{2-[(4-iodo-2,5-dimethylphenoxy)methyl]phenyl}(methoxyimino)ethanoate	A,C,D,E,N,P,Q,R	3H1K	0.72
MPP	3-(3,4-DIMETHOXYPHENYL)PROPIONIC ACID	A,B	2AY3	0.73
IM3	(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID	A,B,C,D	2E82	0.71
EMF	ethyl (1S,2S)-2-(4-hydroxy-3-methoxyphenyl)cyclopropanecarboxylate	A,B	2QZZ	0.79
EMF	ethyl (1S,2S)-2-(4-hydroxy-3-methoxyphenyl)cyclopropanecarboxylate	A,B	2R2G	0.79
BYS	2-BENZO[1,3]DIOXOL-5-YLMETHYL-3-BENZYL-SUCCINIC ACID	A,B	1JJE	0.7
LRG	(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid	A	3B3K	0.71
LRG	(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid	A	3D6D	0.71
GRR	(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid	A	3CDS	0.71
G24	[4-(3-BENZYL-4-HYDROXYBENZYL)-3,5-DIMETHYLPHENOXY]ACETIC ACID	A	1Q4X	0.7
AB8	(1S,3R,8AS)-8-(2-{(4S,6S)-3-(4-HYDROXY-3-METHOXYBENZYL)-4-[2-(METHYLAMINO)-2-OXOETHYL]-2-OXO-1,3-OXAZINAN-6-YL}ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL (2R)-2-METHYLBUTANOATE	A,B	1XDG	0.7
WRR	4-HYDROXY-3-[(1S,3R)-3-HYDROXY-1-PHENYLBUTYL]-2H-CHROMEN-2-ONE	A	1H9Z	0.7
WRS	4-HYDROXY-3-[(1S,3S)-3-HYDROXY-1-PHENYLBUTYL]-2H-CHROMEN-2-ONE	A	1HA2	0.7
C41	ALISKIREN	C,O	2V0Z	0.71
C61	(2R,4S,5S,7S)-5-AMINO-N-BUTYL-4-HYDROXY-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]-2,8-DIMETHYLNONANAMIDE	C,O	2V10	0.71
MAX	MATAIRESINOL	A	2BGM	0.78
MGI	methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate	A	2ZA0	0.73
3A3		A	2CGU	0.7
SIG	STIGMATELLIN	C,D,E	2BCC	0.72
SIG	STIGMATELLIN	C,D,E	3BCC	0.72
VNL	4-HYDROXY-3-METHOXYBENZOATE	A,B,C,D	2AHC	0.71
VNL	4-HYDROXY-3-METHOXYBENZOATE	A	1XLR	0.71
CA2	(1S,3R,4R,5S)-1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)CYCLOHEXANECARBOXYLIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	2BT4	0.7
CIO	CILOMILAST	A,B	1XOM	0.76
CIO	CILOMILAST	A,B	1XLX	0.76